Michael Dreher presents the outcome of the HomeVent registry on the prevalence of hypercapnia in COPD stage 3 and 4 and the upcoming HomeVent Connect study, an important step towards refining the use of telemonitoring with home NIV to improve compliance and care for stable, hypercapnic patients. One to watch if your focus is COPD, NIV and telemonitoring!
Rationale and design of HomeVent Connect, a large prospective study of predictors of compliance with NIV using telemonitoring
- ERS INTERNATIONAL CONGRESS 2019
- WITH MICHAEL DREHER
- RATIONALE AND DESIGN OF HOMEVENT CONNECT, A LARGE PROSPECTIVE STUDY OF PREDICTORS OF COMPLIANCE WITH NIV USING TELEMONITORING
ERS symposium: Rationale and design of HomeVent Connect
Michael Dreher presents the HomeVent connect study, an important step towards refining the use of home NIV with telemonitoring for stable, hypercapnic patients. One to watch if your focus is COPD, NIV and telemonitoring!
Michael Dreher - Head of the Department of Pneumology, Universitätsklinik RWTH Aachen, Germany
Looking for more information?
COPD Research at ResMed
ResMed supports multiple global trials that are investigating outcomes in COPD patients treated with non-invasive ventilation (NIV).Learn more